-
1
-
-
84859541761
-
Who will have health insurance in the future? An updated projection
-
Young RA, DeVoe JE. Who will have health insurance in the future? An updated projection. Am Fam Med. 2012;10(12):156-62.
-
(2012)
Am Fam Med
, vol.10
, Issue.12
, pp. 156-162
-
-
Young, R.A.1
DeVoe, J.E.2
-
2
-
-
84907819068
-
Five myths about cancer care in America
-
Goldman DP, Philipson T. Five myths about cancer care in America. Health Aff (Millwood). 2014;33 (10):1801-04.
-
(2014)
Health Aff (Millwood).
, vol.33
, Issue.10
, pp. 1801-1804
-
-
Goldman, D.P.1
Philipson, T.2
-
3
-
-
77955877759
-
Early palliative care for patients with metastatic non-smallcell lung cancer
-
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-smallcell lung cancer. N Engl J Med. 2010;363(8):733-42.
-
(2010)
N Engl J Med
, vol.363
, Issue.8
, pp. 733-742
-
-
Temel, J.S.1
Greer, J.A.2
Muzikansky, A.3
Gallagher, E.R.4
Admane, S.5
Jackson, V.A.6
-
4
-
-
79959745514
-
Use of colonystimulating factors with chemotherapy: opportunities for cost savings and improved outcomes
-
Potosky AL, Malin JL, Kim B, Chrischilles EA, Makgoeng SB, Howlander N, et al. Use of colonystimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst. 2011;103(12):979-82.
-
(2011)
J Natl Cancer Inst
, vol.103
, Issue.12
, pp. 979-982
-
-
Potosky, A.L.1
Malin, J.L.2
Kim, B.3
Chrischilles, E.A.4
Makgoeng, S.B.5
Howlander, N.6
-
5
-
-
84865372540
-
Outcomes of a specialty pharmacy program for oral oncology medications
-
Tschida SJ, Aslam S, Lal LS, Khan TT, Shrank WH, Bhattarai GR, et al. Outcomes of a specialty pharmacy program for oral oncology medications. Am J Pharm Benefits. 2012; 4(4):165-74.
-
(2012)
Am J Pharm Benefits.
, vol.4
, Issue.4
, pp. 165-174
-
-
Tschida, S.J.1
Aslam, S.2
Lal, L.S.3
Khan, T.T.4
Shrank, W.H.5
Bhattarai, G.R.6
-
6
-
-
84862491211
-
How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies
-
Lakdawalla DN, Romley JA, Sanchez Y, Maclean JR, Penrod JR, Philipson T. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies. Health Aff (Millwood). 2012;31(4):676-82.
-
(2012)
Health Aff (Millwood)
, vol.31
, Issue.4
, pp. 676-682
-
-
Lakdawalla, D.N.1
Romley, J.A.2
Sanchez, Y.3
Maclean, J.R.4
Penrod, J.R.5
Philipson, T.6
-
7
-
-
84907839719
-
Changing physician incentives for affordable, quality cancer care: results of an episode payment model
-
Jul. [Epub ahead of print].
-
Newcomer LN, Gould B, Page RD, Donelan SA, Perkins M. Changing physician incentives for affordable, quality cancer care: results of an episode payment model. J Oncol Pract. 2014 Jul. [Epub ahead of print].
-
(2014)
J Oncol Pract.
-
-
Newcomer, L.N.1
Gould, B.2
Page, R.D.3
Donelan, S.A.4
Perkins, M.5
-
8
-
-
84907839718
-
Impact of financial burden of cancer on survivors' quality of life
-
May. [Epub ahead of print].
-
Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pustzai L, Sanft T, et al. Impact of financial burden of cancer on survivors' quality of life. J Oncol Pract. 2014 May. [Epub ahead of print].
-
(2014)
J Oncol Pract.
-
-
Fenn, K.M.1
Evans, S.B.2
McCorkle, R.3
DiGiovanna, M.P.4
Pustzai, L.5
Sanft, T.6
|